Next Article in Journal
MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization
Next Article in Special Issue
Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
Previous Article in Journal
FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer
Previous Article in Special Issue
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(2), 244; https://doi.org/10.3390/pharmaceutics14020244
Action Date Notes Link
article pdf uploaded. 20 January 2022 15:12 CET Version of Record https://www.mdpi.com/1999-4923/14/2/244/pdf-vor
article supplementary file uploaded. 20 January 2022 15:12 CET - https://www.mdpi.com/1999-4923/14/2/244#supplementary
article xml file uploaded 21 January 2022 09:08 CET Original file -
article xml uploaded. 21 January 2022 09:08 CET Update -
article pdf uploaded. 21 January 2022 09:08 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/244/pdf-vor
article html file updated 21 January 2022 09:10 CET Original file -
article xml file uploaded 27 January 2022 15:09 CET Update -
article xml uploaded. 27 January 2022 15:09 CET Update https://www.mdpi.com/1999-4923/14/2/244/xml
article pdf uploaded. 27 January 2022 15:09 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/244/pdf
article html file updated 27 January 2022 15:10 CET Update -
article html file updated 31 July 2022 05:01 CEST Update https://www.mdpi.com/1999-4923/14/2/244/html
Back to TopTop